Caffeic Acid Phenethyl Ester Protects against Experimental Autoimmune Encephalomyelitis by Regulating T Cell Activities

Table 1

Clinical characteristics of the patients with relapsing MS and noninflammatory disorders.

	MS ()	Control ()
Gender ratio ()	5/2	4/3
Age at onset ()	24 (15-32)	33 (20-47)
Disease course ()	27.5 (7-72)	—
EDSS at sampling	3.25 (2.5-5)	—
EDSS at the last visit	1 (1-2.5)	—
CSF WBC (/μl)	2 (0-20)	1 (0-4)
CSF protein (mg/L)	0.19 (0.12-0.30)	0.14 (0.07-0.34)
Abnormal spinal MRI, (%)	4/7 (57)	0/7 (0)
Treatment, (%)		—
Azathioprine	3/7 (43)
Interferon-β	1/7 (14)
Terflutamide	1/7 (14)
Oral methylprednisolone	2/7 (29)